REG - Tristel PLC - Notice of AGM & Posting of Annual Report &Accounts

TristelAnnouncement

22/11/2024 10:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241122:nRSV3486Na&default-theme=true

RNS Number : 3486N  Tristel PLC  22 November 2024

TRISTEL plc

("Tristel" or the "Company")

 

Notice of AGM and Posting of Annual Report and Accounts

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that the Notice of Annual General Meeting ("AGM") and the 2024
Annual Report and Accounts for the year ended 30 June 2024 have been posted to
shareholders yesterday and is available to download from the investor section
of Company's website - https://investors.tristel.com/financial/
(https://investors.tristel.com/financial/)

 

The Company's AGM will be held on Monday, 16 December 2024 at 11.00am at the
Company's headquarters, Unit 1b Lynx Business Park, Fordham Road Snailwell,
Newmarket, Cambridgeshire, CB8 7NY.

 

 

For further information please contact:

 

 Tristel plc                                                                  Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                        www.investors.tristel.com (http://www.investors.tristel.com/)
 Liz Dixon, Chief Financial Officer

 Walbrook PR Ltd                                                              Tel: 020 7933 8780 or tristel@walbrookpr.com (mailto:tristel@walbrookpr.com)
 Paul McManus / Lianne Applegarth / Alice Woodings    Mob: 07980 541 893/ 07584 391 303/ 07407 804 654

 Cavendish Capital Markets Ltd                                                Tel: 020 7220 0500
 Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (ECM) / Louise Talbot (Sales)

 

About Tristel plc

 

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 250 people across 14
subsidiaries selling into 40 countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% (targets to
be updated in February 2024) and the business is profitable, with no debt and
has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAUUURRSRUAUAA